Russia – RDIF confirms Sputnik V COVID vaccine’s efficacy

The Russian Direct Investment Fund (RDIF) has confirmed efficacy of over 90% for the Sputnik V vaccine.

Evaluation of efficacy was carried out among volunteers (22,714) 21 days after receiving the first dose of the vaccine or placebo upon reaching the third and final statistically significant representative control point of the trial.

The data analysis at the final control point of the trials demonstrated a 91.4% efficacy rate…